The interruption of IGF2 promoter regulation is a common feature of human cardiovascular diseases, which indicates that frequent deletion of biallelic IGF2 expression due to the deletion of P1 activation can be used as a diagnostic or observational marker for human cardiovascular diseases (90, 91). The gene discussed is IGF2; the disease is cardiovascular disorder.